Clinical Trial Update: Efficacy of XP20B Following Bunionectomy Surgery [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating XP20B for postoperative pain after bunionectomy has completed, reporting efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain
• Postoperative Pain

Drugs mentioned

• XP20B

Snippet

Sponsor: Xanodyne Pharmaceuticals | Conditions: Acute Pain | Phase 3 | Status: COMPLETED